Olivia Kim McManus
Neurology with Special Qualifications in Child Neurology · San Diego, CANPI 1174870067
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,658 of the $10,658 with a category attached, or 62.5%. 24 manufacturers reported payments, led by UCB, Inc. at 57.4% of the total. 2025 is the largest year on record at $5,946, 4.0 times the $1,485 reported in 2019.
Across 230 payments — averaging $46.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$6K
- Jazz Pharmaceuticals Inc.$953
- Sunovion Pharmaceuticals Inc.$791
- Neuropace, Inc.$567
- Neurelis, Inc.$350
- Livanova USA, Inc.$324
- plus $2K from 18 others
Across 2 payments — averaging $2952.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$6K
What the payments were for
- Speaking & faculty fees$4,00038%
- Food & beverage$6,65862%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 46 | $6,118 |
| Jazz Pharmaceuticals Inc. | 16 | $953 |
| Sunovion Pharmaceuticals Inc. | 55 | $791 |
| Neuropace, Inc. | 13 | $567 |
| Neurelis, Inc. | 18 | $350 |
| Livanova USA, Inc. | 21 | $324 |
| SK Life Science, Inc. | 3 | $208 |
| Mallinckrodt Enterprises LLC | 8 | $204 |
| Greenwich Biosciences, Inc. | 8 | $190 |
| Catalyst Pharmaceuticals, Inc. | 6 | $157 |
| Acadia Pharmaceuticals Inc | 6 | $142 |
| Immedica Pharma US, Inc. | 4 | $107 |
| Eisai Inc. | 6 | $94 |
| Upsher-smith Laboratories LLC | 3 | $72 |
| CSL Behring | 4 | $70 |
| Zimmer Biomet | 1 | $65 |
| Aquestive Therapeutics, Inc. | 3 | $65 |
| Biocodex, Inc. | 2 | $48 |
| Aucta Pharmaceuticals, Inc. | 2 | $38 |
| NS Pharma, Inc. | 1 | $23 |
| Novartis | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Biomarin Pharmaceutical Inc. | 1 | $18 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nayzilam$4,124
- Epidiolex$424
- Fintepla$386
- RNS Neurostimulator Kit$346
How this compares
$10,658 in reported general payments places this provider in the 80th percentile of 216 neurology with special qualifications in child neurology providers in California.
See all neurology with special qualifications in child neurology providers in California →
Other neurology with special qualifications in child neurology in San Diego
- Brittany PassiakSan Diego$90K
- Joseph GleesonSan Diego$69K
- John CrawfordSan Diego$27K
- Richard HaasSan Diego$27K
- Shifteh SattarSan Diego$21K
- Jennifer YangSan Diego$15K
- Doris TraunerSan Diego$15K
- Katherine LongardnerSan Diego$11K
- Aliya FrederickSan Diego$7K
- Michael ChezSacramento$374K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.